177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 18, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 18, 2018Unknown status
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 3, 2022Completed
Condition(s):Castration-resistant Prostate CancerLast Updated:March 20, 2024Recruiting
Condition(s):Castration-resistant Prostate CancerLast Updated:January 26, 2024Not yet recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:March 21, 2024Active, not recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 23, 2023Recruiting
Condition(s):Prostate Cancer; Metastatic Castration-resistant Prostate Cancer; Castration Resistant Prostatic CancerLast Updated:March 4, 2024Recruiting
Condition(s):Castration-resistant Prostate CancerLast Updated:January 6, 2022Completed
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:February 28, 2024Active, not recruiting
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:March 27, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.